NasdaqGS:RGENLife Sciences
Reassessing Repligen (RGEN) Valuation After Recent Share Price Weakness
What Repligen’s recent share performance might be telling investors
Repligen (RGEN) has drawn attention after a recent pullback, with the stock showing a 4.4% one day decline and double digit negative returns over the past week and month.
For investors tracking the name over longer periods, Repligen’s shares have also delivered negative total returns year to date, over the past year, and over the past 3 years, prompting closer scrutiny of what the current price may already reflect.
See our...